100
Participants
Start Date
January 31, 2005
Primary Completion Date
September 30, 2006
Study Completion Date
September 30, 2007
OraVescent fentanyl (OVF)
NYU Pain Management Center, New York
Research Across America, New York
Lehigh Valley Hospital, Allentown
University of Pennsylvania, Philadelphia
Brody School of Medicine, Greenville
Charleston Hematology Oncology, PA, Charleston
Center for Prospective Outcome, Marietta
Gulf Coast Pain Specialists, Pensacola
Lovelace Scientific Resources, Miami
Hematology Oncology Associates of Treasure Coast, Port Saint Lucie
Cullman Oncology and Hematology, Cullman
Gabrail Cancer Center, Canton
Iowa Pain Management Clinic, PC, Des Moines
Donald Berdeaux, Great Falls
Great Falls Clinic, LLP, Great Falls
University of Rochester, San Antonio
Cache Valley Cancer Treatment and Research Clinic, Inc., West Point
Lifetree Clinical Research, Salt Lake City
Southern Nevada Cancer Research, Las Vegas
Pacific Clinical Research, Santa Monica
Clinical Trials & Research Associates, Inc., Montebello
San Diego Hospice & Palliative Care, San Diego
Compassionate Cancer Center, Fountain Valley
Advanced Clinical Research Institute, Anaheim
Pacific Cancer Medical Center, Anaheim
Compassionate Cancer Care Medical Group, Corona
Lead Sponsor
Cephalon
INDUSTRY